CORC

在结果中检索

CORC

浏览/检索结果: 共20条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
一种低损伤的铟镓砷探测器p+n结制备方法 专利
专利号: 201510296103.1, 申请日期: 2015-06-02, 公开日期: 2017-03-22
作者:  1曹高奇 2 唐恒敬 3 程吉凤 4石 铭5王 瑞6邵秀梅7李庆法 8 李 雪 9 龚海梅
收藏  |  浏览/下载：16/0  |  提交时间：2017/12/12
Symptom and Quality of Life Improvement in LUX-Lung 6 An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2015, 卷号: 10, 期号: 6
作者:  Geater, Sarayut L.;  Xu, Chong-Rui;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/04
Symptom and Quality of Life Improvement in LUX-Lung 6 An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2015, 卷号: 10, 期号: 6
作者:  Geater, Sarayut L.;  Xu, Chong-Rui;  Zhou, Caicun;  Hu, Cheng-Ping;  Feng, Jifeng
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials 期刊论文
LANCET ONCOLOGY, 2015, 卷号: 16, 期号: 2
作者:  Yang, James Chih-Hsin;  Wu, Yi-Long;  Schuler, Martin;  Sebastian, Martin;  Popat, Sanjay
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/04
Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial 期刊论文
Head & Neck, 2015, 卷号: 37, 期号: 8, 页码: 1081-1087
作者:  Guo, Ye;  Shi, Mei;  Yang, Ankui;  Feng, Jifeng;  Zhu, Xiaodong
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03
Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer. 期刊论文
Journal of Thoracic Oncology, 2015, 卷号: 10, 期号: 6, 页码: 883-889
作者:  Geater, Sarayut L
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials 期刊论文
The Lancet Oncology, 2015, 卷号: 16, 期号: 2, 页码: 141-151
作者:  Yang, James Chih-Hsin*;  Wu, Yi-Long;  Schuler, Martin;  Sebastian, Martin;  Popat, Sanjay
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer. 期刊论文
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, 卷号: 33, 期号: 19, 页码: 2197-U108
作者:  Zhou, Caicun*;  Wu, Yi-Long;  Chen, Gongyan;  Liu, Xiaoqing;  Zhu, Yunzhong
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/03
China experts consensus on icotinib for non-small cell lung cancer treatment (2015 version) 期刊论文
ANNALS OF TRANSLATIONAL MEDICINE, 2015, 卷号: 3
作者:  Shi, Yuankai[1,2];  Sun, Yan[1,2];  Ding, Cuimin[3];  Wang, Ziping[1,2];  Wang, Changli[4]
收藏  |  浏览/下载：6/0  |  提交时间：2019/04/25
Platinum-based chemotherapy plus cetuximab first-line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open-label, single-arm, multicenter trial 期刊论文
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 卷号: 37, 期号: 8
作者:  Guo, Ye;  Shi, Mei;  Yang, Ankui;  Feng, Jifeng;  Zhu, Xiaodong
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace